Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 43 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.
Gertz MA, Cohen AD, Comenzo RL, Kastritis E, Landau HJ, Libby EN, Liedtke M, Sanchorawala V, Schönland S, Wechalekar A, Zonder JA, Palladini G, Walling J, Guthrie S, Nie C, Karp C, Jin Y, Kinney GG, Merlini G
Blood, 142(14):1208-1218, 01 Oct 2023
Cited by: 7 articles | PMID: 37366170 | PMCID: PMC10644097
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Nooka AK, Cohen AD, Lee HC, Badros A, Suvannasankha A, Callander N, Abdallah AO, Trudel S, Chari A, Libby EN, Chaudhry M, Hultcrantz M, Kortüm KM, Popat R, Sborov D, Hakim S, Lewis E, Gorsh B, Bhushan B, [...] Lonial S
Cancer, 129(23):3746-3760, 25 Aug 2023
Cited by: 13 articles | PMID: 37622738
Add to export list
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ
Lancet Oncol, 24(7):811-822, 01 Jul 2023
Cited by: 18 articles | PMID: 37414012
Add to export list
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL.
Graf SA, Lynch RC, Ujjani CS, Gooley TA, Rasmussen H, Coffey DG, Cowan AJ, Smith SD, Shadman M, Warren EH, Libby EN, Greninger AL, Fromm JR, Gopal AK
Blood Adv, 7(5):687-696, 01 Mar 2023
Cited by: 1 article | PMID: 36385536 | PMCID: PMC9984960
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R²) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, [...] Salles G
J Clin Oncol, 40(28):3239-3245, 10 Aug 2022
Cited by: 14 articles | PMID: 35947804 | PMCID: PMC9553375
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, Medvedova E, McCarthy PL, Libby EN, Voorhees PM, Orlowski RZ, Anderson LD, Zonder JA, Milner CP, Gasparetto C, Agha ME, Khan AM, Hurd DD, Gowin K, [...] DETERMINATION Investigators
N Engl J Med, 387(2):132-147, 05 Jun 2022
Cited by: 137 articles | PMID: 35660812 | PMCID: PMC10040899
Add to export list Free full text in Europe PMC
Diagnosis and Management of Multiple Myeloma: A Review.
Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN
JAMA, 327(5):464-477, 01 Feb 2022
Cited by: 303 articles | PMID: 35103762
Add to export list Review
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Lynch RC, Cassaday RD, Smith SD, Fromm JR, Cowan AJ, Warren EH, Shadman MS, Shustov A, Till BG, Ujjani CS, Libby EN, Philip M, Coye H, Martino CN, Bhark SL, Morris K, Rasmussen H, Behnia S, Voutsinas J, Gopal AK
Lancet Haematol, 8(8):e562-e571, 01 Aug 2021
Cited by: 20 articles | PMID: 34329577 | PMCID: PMC8457616
Add to export list Free full text in Europe PMC
High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.
Coffey DG, Cowan AJ, DeGraaff B, Martins TJ, Curley N, Green DJ, Libby EN, Silbermann R, Chien S, Dai J, Morales A, Gooley TA, Warren EH, Becker PS
JCO Precis Oncol, 5:PO.20.00442, 06 Apr 2021
Cited by: 5 articles | PMID: 34250400 | PMCID: PMC8232547
Add to export list Free full text in Europe PMC
Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective Analysis.
Cowan AJ, Stevenson PA, Green DJ, Tuazon S, Libby EN, Kwok M, Lee S, Coffey DG, Gopal AK, Holmberg LA
Transplant Cell Ther, 27(8):661.e1-661.e6, 22 Apr 2021
Cited by: 7 articles | PMID: 33895403
Add to export list
Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis.
Leedy DJ, Vasbinder A, Huang HD, Fernandes R, Cowan AJ, Gopal AK, Kirkpatrick JN, Libby EN, Cheng RK
JACC CardioOncol, 2(4):647-649, 17 Nov 2020
Cited by: 2 articles | PMID: 33511354 | PMCID: PMC7839948
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Cowan AJ, Baldomero H, Atsuta Y, Mikhael J, Aljurf M, Seber A, Greinix H, Koh M, Worel N, Libby EN, Pasquini M, Galeano S, Saber W, Iida M, Jaimovich G, Rolon JM, Kodera Y, Benakli M, Nosa BG, [...] Niederwieser D
Biol Blood Marrow Transplant, 26(12):2372-2377, 23 Aug 2020
Cited by: 12 articles | PMID: 32846200 | PMCID: PMC7767639
Add to export list Free full text in Europe PMC
Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia.
Castillo JJ, Libby EN, Ansell SM, Palomba ML, Meid K, Flynn CA, Leventoff C, Hergott CB, Sewastianik T, Morgan EA, Carrasco R, Fromm JR, Yang G, Hunter Z, Treon SP
Blood Adv, 4(20):5089-5092, 01 Oct 2020
Cited by: 8 articles | PMID: 33085756 | PMCID: PMC7594378
Add to export list Free full text in Europe PMC
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy.
Percival MM, Lynch RC, Halpern AB, Shadman M, Cassaday RD, Ujjani C, Shustov A, Tseng YD, Liu C, Pergam S, Libby EN, Scott BL, Smith SD, Green DJ, Gopal AK, Cowan AJ
JCO Oncol Pract, 16(9):571-578, 05 May 2020
Cited by: 16 articles | PMID: 32369409 | PMCID: PMC7489485
Add to export list Free full text in Europe PMC
KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation.
Cowan AJ, Green DJ, Karami M, Becker PS, Tuazon S, Coffey DG, Hyun TS, Libby EN, Gopal AK, Holmberg LA
Clin Lymphoma Myeloma Leuk, 20(9):602-609, 14 Apr 2020
Cited by: 4 articles | PMID: 32457024
Add to export list
The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma.
Li A, Wu Q, Warnick G, Li S, Libby EN, Garcia DA, Lyman GH
Ann Hematol, 99(1):121-126, 26 Nov 2019
Cited by: 12 articles | PMID: 31773215
Add to export list
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.
Li A, Wu Q, Luo S, Warnick GS, Zakai NA, Libby EN, Gage BF, Garcia DA, Lyman GH, Sanfilippo KM
J Natl Compr Canc Netw, 17(7):840-847, 01 Jul 2019
Cited by: 56 articles | PMID: 31319391 | PMCID: PMC7808759
Add to export list Free full text in Europe PMC
Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study.
Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Hoos A, Gupta I, Bragulat V, He Z, Opalinska JB, Cohen AD
Blood Cancer J, 9(4):37, 20 Mar 2019
Cited by: 112 articles | PMID: 30894515 | PMCID: PMC6426965
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.
Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN, Smith SD, Gooley T, Gopal AK
Br J Haematol, 186(1):159-162, 28 Dec 2018
Cited by: 1 article | PMID: 30592026 | PMCID: PMC6589112
Add to export list Free full text in Europe PMC
Triplet therapies - the new standard of care for multiple myeloma: how to manage common toxicities.
Paner A, Okwuosa TM, Richardson KJ, Libby EN
Expert Rev Hematol, 11(12):957-973, 04 Dec 2018
Cited by: 4 articles | PMID: 30339769
Add to export list Review
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD
Lancet Oncol, 19(12):1641-1653, 12 Nov 2018
Cited by: 131 articles | PMID: 30442502 | PMCID: PMC6328058
Add to export list Free full text in Europe PMC
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
Budde LE, Wu D, Martin DB, Philip M, Shustov AR, Smith SD, Gooley TA, Chen TL, Libby EN, Chen EY, Kojouri K, Langerak A, Roden JE, Press OW, Gopal AK
Br J Haematol, 183(4):601-607, 14 Sep 2018
Cited by: 5 articles | PMID: 30596402 | PMCID: PMC6314205
Add to export list Free full text in Europe PMC
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, [...] RELEVANCE Trial Investigators
N Engl J Med, 379(10):934-947, 01 Sep 2018
Cited by: 136 articles | PMID: 30184451
Add to export list
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.
Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, Foreman K, Gupta R, Harvey J, Hosgood HD, Jakovljevic M, Khader Y, Linn S, Lad D, Mantovani L, Nong VM, Mokdad A, Naghavi M, Postma M, [...] Fitzmaurice C
JAMA Oncol, 4(9):1221-1227, 01 Sep 2018
Cited by: 275 articles | PMID: 29800065 | PMCID: PMC6143021
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Plasma cell diseases and organ transplant: A comprehensive review.
Cowan AJ, Johnson CK, Libby EN
Am J Transplant, 18(5):1046-1058, 01 May 2018
Cited by: 3 articles | PMID: 29524307
Add to export list Review

1-25 of 43 results

1 2

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding